Clinical Trials
10 trialsNCT00804128 2024-01-19
Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)
University of California, San Francisco
Completed
NCT00375830 2023-12-12
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
Stanford University
Phase 2 Completed
NCT04132843 2022-11-21
Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
M.D. Anderson Cancer Center
Phase NA Completed
NCT03404648 2021-02-08
Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI
Mayo Clinic
Phase 3 Completed
NCT01989000 2018-06-27
MIPA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT00522951 2017-08-28
SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study
Bayer
Phase 3 Completed
NCT01995240 2017-03-20
REMP
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT01050829 2014-12-30
Gadobutrol Magnevist-controlled Body Study
Bayer
Phase 3 Completed
NCT01067976 2014-11-11
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
Bayer
Phase 3 Completed
NCT01104584 2014-11-11
GEMMA 2
Bayer
Phase 3 Completed